{
    "clinical_study": {
        "@rank": "139403", 
        "acronym": "EDUCA", 
        "arm_group": [
            {
                "arm_group_label": "Group thorough VKA (antivitamin K)education", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "control group", 
                "arm_group_type": "Active Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "To meet the wishes of the Ministry of Health, the division of Cardiology University Hospital\n      of Clermont Ferrand, combining the cardiology and cardiac surgery department, has developed\n      since January 2009, a therapeutic education to use oral anticoagulants, in collaboration\n      with the functional rehabilitation center Durtol. All patients under VKA, are formed by\n      nurses. The purpose of this local study, in cardiac surgery department, is to evaluate the\n      therapeutic impact of two methods of comprehensive education, one conventional and performed\n      by nurses service, less elaborate, relying solely on the book Information from The National\n      Security Agency of Medicines and Health Products, the other based on more detailed documents\n      created by a multidisciplinary group. Various studies show that the effect of therapeutic\n      education is observed only during the first six months and then disappears.\n\n      This study is the first French study evaluating the impact of a comprehensive education to\n      oral anticoagulation according to the latest recommendations of the National Security Agency\n      of Medicines and Health Products and the French National Health Authority."
        }, 
        "brief_title": "Benefits of a Comprehensive Patient Education on Oral Anticoagulant Compared to Conventional Hospital Education", 
        "completion_date": {
            "#text": "December 2012", 
            "@type": "Anticipated"
        }, 
        "condition": "Cardiac Surgery", 
        "detailed_description": {
            "textblock": "To meet the wishes of the Ministry of Health, the division of Cardiology University Hospital\n      of Clermont Ferrand, combining the cardiology and cardiac surgery department, has developed\n      since January 2009, a therapeutic education to use oral anticoagulants, in collaboration\n      with the functional rehabilitation center Durtol. All patients under VKA, are formed by\n      nurses. The purpose of this local study, in cardiac surgery department, is to evaluate the\n      therapeutic impact of two methods of comprehensive education, one conventional and performed\n      by nurses service, less elaborate, relying solely on the book Information from The National\n      Security Agency of Medicines and Health Products, the other based on more detailed documents\n      created by a multidisciplinary group. Various studies show that the effect of therapeutic\n      education is observed only during the first six months and then disappears.\n\n      This study is the first French study evaluating the impact of a comprehensive education to\n      oral anticoagulation according to the latest recommendations of the National Security Agency\n      of Medicines and Health Products and the French National Health Authority."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Adults, male or female, over 18 years\n\n          -  After cardiac surgery\n\n          -  Requiring an oral anticoagulant in the long term (> 12 months)\n\n          -  Accepting the principle of extended follow-up\n\n          -  Voluntary Consent, written and signed by patients"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "186", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 13, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01699282", 
            "org_study_id": "CHU-0121"
        }, 
        "intervention": [
            {
                "arm_group_label": "Group thorough VKA (antivitamin K)education", 
                "description": "Evaluate benefits of a comprehensive patient education on oral anticoagulant compared to conventional hospital education", 
                "intervention_name": "VKA (antivitamin K) education", 
                "intervention_type": "Behavioral"
            }, 
            {
                "arm_group_label": "control group", 
                "description": "Group thorough VKA education V.S. control group (conventional hospital education)", 
                "intervention_name": "conventional hospital education", 
                "intervention_type": "Behavioral"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Antivitamins K", 
                "Anticoagulants"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "oral anticoagulant", 
            "in the long term (> 12 months)"
        ], 
        "lastchanged_date": "October 1, 2012", 
        "location": {
            "contact": {
                "email": "placarin@chu-clermontferrand.fr", 
                "last_name": "Patrick LACARIN", 
                "phone": "04 73 75 11 95"
            }, 
            "facility": {
                "address": {
                    "city": "Clermont-Ferrand", 
                    "country": "France", 
                    "zip": "63003"
                }, 
                "name": "CHU de Clermont-Ferrand"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "2", 
        "official_title": "Benefits of a Comprehensive Patient Education on Oral Anticoagulant Compared to Conventional Hospital Education.", 
        "overall_contact": {
            "email": "placarin@chu-clermontferrand.fr", 
            "last_name": "Patrick LACARIN", 
            "phone": "04 73 75 11 95"
        }, 
        "overall_official": {
            "affiliation": "University Hospital, Clermont-Ferrand", 
            "last_name": "Kasra Azarnoush", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "France: Ministry of Health"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "December 2012", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "knowledge test on anticoagulant treatment", 
            "safety_issue": "Yes", 
            "time_frame": "after 12 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01699282"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "University Hospital, Clermont-Ferrand", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University Hospital, Clermont-Ferrand", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2010", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label", 
        "study_type": "Interventional", 
        "verification_date": "October 2012"
    }
}